시장보고서

상품코드

1804882

동종 요법 시장 규모와 예측(2021-2032년) : 세계 및 지역 점유율, 동향, 성장 기회 - 분석 범위(공급원별, 유형별, 용도별, 최종 사용자별, 지역별)

Homeopathy Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Source, Type, Application, End User, and Geography

발행일: 2025년 07월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 257 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

동종 요법 시장 규모는 2024년 128억 8,000만 달러에서 2031년에는 420억 6,000만 달러에 이를 것으로 예상됩니다. 이 시장은 2025-2031년 사이에 18.50%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 추정됩니다. 시장 성장을 가속하는 주요 요인으로는 생활 습관병과 만성 질환의 급증, 동종 요법 의약품의 채용 증가 등이 있습니다. 또한 식물 기반의 새로운 동종 요법 의약품 출시는 예측 기간 동안 시장을 밀어 올릴 가능성이 높습니다. 그러나 동종 요법 의약품의 임상 증거의 부족은 시장 성장 억제요인 중 하나입니다.

게다가 World Obesity Atlas 2024에 따르면, 세계의 비감염성 질환(NCDs)에 의한 연간 성인 사망자 수 4,100만명 중 500만명이 고체중 지수(BMI) 때문입니다. 그중 400만명 가까이는 당뇨병, 뇌졸중, 관동맥성 심질환, 암에 의한 것뿐입니다. 높은 BMI는 이러한 네 가지 주요 NCDs에 의해 매년 1억 2,000만 명이 넘는 성인을 잃는 원인이 되고 있습니다. 당뇨병, 천식, 심혈관 질환, 스트레스, 불안과 같은 비 전염성 질환과 같은 만성 질환은 장기 관리가 필요합니다. 전통적인 치료는 부작용과 제한을 수반합니다. 동종 요법은 온화하고 비 침습적인 대체 요법을 제공하며 고립 된 증상뿐만 아니라 전체 환자를 치료하는 데 중점을 둡니다. 이 접근법은 더 안전하고 지속 가능한 치료 옵션을 찾고있는 만성 질환으로 고통받는 사람들의 요구에 잘 맞습니다.

세계보건기구(WHO)에 따르면 2024년에는 5세 미만의 어린이 중 3,500만 명이 체중 과다로 진단받았습니다. 저·중소득국에서는 체중 과다가 증가하고 있습니다. 아프리카에서는 2000년 이후 5세 미만의 과체중 아동 수가 12.1% 가까이 증가하고 있습니다. 2024년에는 5세 미만의 체중 과다 또는 비만과 공존하는 어린이의 거의 절반이 아시아에 살고 있었습니다.

비만, 당뇨병, 심혈관 질환과 같은 NCDs 관리에서 동종 요법의 역할은 특히 인도와 같은 NCDs의 부담이 큰 국가에서 인정되고 있습니다. 이 인식은 통합 의료를 촉진하는 AYUSH 관할의 정부 프로그램에 의해 지원됩니다. 동종 요법 의약품은 알로파시 치료에 비해 합리적인 가격이며 독성 부작용이 없기 때문에 어린이, 임산부, 노인 등 다양한 환자를 매료하고 있습니다.

경쟁업체별 분석은 제품 포트폴리오(제품 만족도, 제품 특징, 이용가능성), 최근 시장 동향(합병·인수, 신제품 발매·강화, 투자·자금 조달, 수상, 합의, 제휴·협력, 인지, 확대), 경쟁 구도의 보다 나은 의사결정과 이해를 돕는 지역적 프레즌스에 따라 호메오파스 분류 이 보고서는 세계의 동종 요법 시장의 주요 공급업체의 최근 중요한 동향과 혁신을 깊이 탐구합니다. 주요 시장 기업은 Fourrts; Boiron; Biologische Heilmittel Heel Gmbh; Dr Reckeweg & Co GmbH; Homeocan Inc; Dr. Schwabe Holding SE & Co. KG; &Co.KG., Natura, Fusion Homoeopathics입니다.

공급원에 따라 동종 요법 시장은 식물, 미네랄, 동물로 구분됩니다. 2024년 동종 요법 시장에서는 식물 부문이 가장 큰 점유율을 차지했습니다.

유형별로 동종 요법 시장은 희석액, 팅크, 생화학, 정제, 연고 등으로 분류됩니다. 희석액 부문은 2024년 동종 요법 시장에서 가장 큰 점유율을 차지했으며 2025-2031년에 가장 높은 CAGR을 나타낼 것으로 예측됩니다.

용도별로 동종 요법 시장은 신경학, 소화기학, 호흡기학, 피부과학, 면역학으로 분류됩니다. 신경 분야는 2024년 동종 요법 시장에서 가장 큰 점유율을 차지했습니다. 편두통, 불안, 우울증과 같은 신경 증상은 주로 라이프 스타일 변화, 도시 지역의 스트레스, 노화 및 진단 능력 향상으로이 지역에서 꾸준히 증가하고 있습니다. WHO에 따르면 신경 질환은 중저소득 국가에서 장애의 주요 원인 중 하나입니다. 신경 질환에 대한 전통적인 치료법은 장기간의 부작용과 제한된 효능만을 수반하는 경우가 많습니다. 따라서 환자는 온화하고 비침습적인 구제를 요구하는 동종 요법에 주목하고 있습니다. 트리카부트와 같은 동종 요법 요법은 특히 만성 증상에 대해 의약품보다 안전한 대안으로 인식되고 있습니다. 동종 요법의 전문가들은 격렬하고 돌발적인 불안과 공황에 대해 삼각형을 권장합니다. 신경학적 문제를 목표로 하는 신경과학에 초점을 맞춘 동종 요법 치료는 꾸준히 인기가 높아지고 있으며, 장기적인 치료가 필요한 환자의 요구에 대응하고 있습니다.

최종 사용자별로 동종 요법 시장은 동종 요법 클리닉, 소매 약국, 전자 소매 업체 등으로 구분됩니다. 동종 요법 클리닉 분야는 2024년 동종 요법 시장에서 가장 큰 점유율을 차지했고 2025-2031년에 가장 높은 CAGR을 나타낼 것으로 예측됩니다.

동종 요법 시장에서 사업을 전개하는 기업은 다양한 유기적 및 무기적 전략을 채택하고 있습니다. 유기적 전략에는 주로 제품 시장과 제품 승인이 포함됩니다. 시장에서 볼 수 있는 무기적 성장 전략에는 인수, 제휴 및 파트너십이 있습니다. 이러한 성장 전략을 통해 시장 진출기업은 전체 시장 성장에 기여하고 비즈니스를 확대하고 지리적 존재를 높일 수 있습니다. 또한 인수 및 제휴와 같은 전략은 고객 기반을 강화하고 제품 포트폴리오를 확대하는 데 도움이 됩니다. 동종 요법 시장의 주요 기업에 의한 중요한 발전 중 일부는 다음과 같습니다.

2024년 Boiron사는 신뢰성이 높은 ThroatCalm 시리즈에 새롭게 ThroatCalm Spray를 발매해 제품 라인을 확대했습니다. 이 제품의 출시로 회사는 제품 포트폴리오를 더욱 강화할 수 있게 되었습니다.

2022년 EW 헬스케어 파트너스는 보일론의 소수주주 지분을 25% 취득하고 보일론의 성장을 더욱 가속화하기 위해 새로운 의료 분야에 대한 제품 제공을 확대하고 기존 플랫폼을 활용하여 특히 미국에서 추가 제품을 출시했습니다.

동종 요법 시장 : 주요 시장 역학
시장 성장 촉진요인
- 동종 요법 의학 채용률 상승
- 생활습관병 및 만성질환 증가
시장 성장 억제요인
- 동종 요법 의약품의 임상 증거의 부족
시장 기회
- 의료 지출의 급증과 상환 정책의 진화
향후의 동향
- 식물성 보충제에 대한 수요 증가와 혁신적인 동종 요법 치료의 출시
성장 촉진요인과 억제요인의 영향

제6장 동종 요법 시장 : 세계 시장 분석

동종 요법 시장의 수익(2021-2031년)
동종 요법 시장 예측·분석

제7장 동종 요법 시장 분석 : 공급원별

식물
광물
동물

제8장 동종 요법 시장 분석 : 유형별

희석제
팅크제
생화학
정제
연고
기타

제9장 동종 요법 시장 분석 : 용도별

신경학
위장병학
호흡기
피부과
면역학
기타

제10장 동종 요법 시장 분석 : 최종 사용자별

동종 요법 클리닉
소매 약국
전자 소매업체
기타

제11장 동종 요법 시장 : 지역별 분석

북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 인도
- 중국
- 일본
- 호주
- 한국
- 기타 아시아태평양
중동 및 아프리카
- 아랍에미리트(UAE)
- 사우디아라비아
- 남아프리카
- 기타 중동 및 아프리카
중남미
- 브라질
- 아르헨티나
- 기타 중남미

제12장 경쟁 구도

히트 맵 분석 : 주요 기업별
기업의 포지셔닝과 집중도

제13장 업계 정세

제품 출시, 제품 승인
기업 합병·인수(M&A)
파트너십
기업 뉴스

제14장 기업 프로파일

Fourrts
Boiron
Biologische Heilmittel Heel GmbH
Dr Reckeweg & Co GmbH
Homeocan Inc
Dr. Schwabe Holding SE & Co. KG
Hahnemann Laboratories, Inc
Qvik-Homeopathy
Hevert-Arzneimittel GmbH & Co. KG.
Natura
Fusion Homoeopathics

제15장 부록

KTH 25.09.10

The homeopathy market size is projected to reach US$ 42.06 billion by 2031 from US$ 12.88 billion in 2024. The market is estimated to register a CAGR of 18.50% during 2025-2031. Major factors driving the market growth include a surging incidence of lifestyle-related and chronic diseases and the rising adoption of homeopathy medicines. Further, the launch of plant-based and new homeopathic medicines will likely boost the market during the forecast period. However, the lack of clinical evidence for homeopathy medicines is among the market deterrents.

Moreover, as per the World Obesity Atlas 2024, of the 41 million adult deaths yearly due to non-communicable diseases (NCDs), 5 million are driven by high body mass index (BMI). Nearly 4 million of these are from diabetes, stroke, coronary heart disease, and cancer alone. A high BMI is accountable for over 120 million adult person-years lost to these four leading NCDs each year. Chronic conditions like non-communicable diseases, such as diabetes, asthma, cardiovascular diseases, stress, and anxiety, require long-term management. Conventional treatments often come with side effects or limitations. Homeopathy offers a gentle and non-invasive alternative, focusing on treating the patient as a whole rather than just isolated symptoms. This approach aligns well with the needs of individuals suffering from chronic diseases who are looking for safer and more sustainable treatment options.

As per the World Health Organization (WHO), in 2024, an estimated 35 million children under the age of 5 were overweight. Overweight is on the rise in low-and middle-income nations. In Africa, the number of overweight children under five has increased by nearly 12.1% since 2000. Almost half of the children under five who were overweight or living with obesity in 2024 lived in Asia.

Homeopathy's role in managing NCDs such as obesity, diabetes, and cardiovascular diseases is gaining recognition, particularly in countries with high NCD burdens like India. This recognition is supported by government programs under the Ministry of AYUSH, which promote integrative care. The affordability of homeopathic medicines, compared to allopathic treatments, along with their lack of toxic side effects, attracts a diverse range of patients, including children, pregnant women, and the elderly.

The comparative company analysis evaluates and categorizes the homeopathy market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global homeopathy market. The key market players are Fourrts; Boiron; Biologische Heilmittel Heel Gmbh; Dr Reckeweg & Co GmbH; Homeocan Inc; Dr. Schwabe Holding SE & Co. KG; Hahnemann Laboratories, Inc; Qvik - Homeopathy; Hevert-Arzneimittel GmbH & Co. KG.; Natura; and Fusion Homoeopathics.

Based on source, the homeopathy market is segmented into plants, minerals, and animals. The plants segment held the largest share of the homeopathy market in 2024.

By type, the homeopathy market is classified into dilutions, tinctures, biochemics, tablets, ointments, and others. The dilutions segment held the largest share of the homeopathy market in 2024, and it is expected to register the highest CAGR during 2025-2031.

According to application, the homeopathy market is categorized into neurology, gastroenterology, respiratory, dermatology, and immunology. The neurology segment held the largest share of the homeopathy market in 2024. Neurological conditions such as migraine, anxiety, and depression are rising steadily in the region, largely due to lifestyle changes, urban stress, aging populations, and greater diagnostic capabilities. According to the WHO, neurological disorders are among the leading causes of disability in low- and middle-income countries. Conventional treatments for neurological conditions often come with long-term side effects or limited efficacy. Therefore, patients are turning to homeopathy for gentle, non-invasive relief. Homeopathic remedies such as Aconite are perceived as safer alternatives to pharmaceutical drugs, especially for chronic conditions. Homeopathy practitioners recommend Aconite for intense, sudden anxiety or panic. Targeting neurological problems, homeopathic remedies with a neuroscience focus are steadily growing in popularity and addressing the needs of patients who require long-term care.

Per end user, the homeopathy market is segmented into homeopathic clinics, retail pharmacies, e-retailers, and others. The homeopathic clinics segment held the largest share of the homeopathy market in 2024 and is anticipated to register the highest CAGR during 2025-2031.

Various organic and inorganic strategies are adopted by companies operating in the homeopathy market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the homeopathy market are listed below.

In 2024, Boiron expanded its product line with the launch of ThroatCalm Spray, the latest addition to its trusted ThroatCalm line. This product launch enables the company to strengthen its product portfolio further.

In 2022, EW Healthcare Partners acquired a 25% minority stake in Boiron to help further accelerate Boiron's growth by expanding its offering into additional healthcare verticals and capitalizing on the existing platform to launch additional products, in particular in the US.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Homeopathy Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Homeopathy Market - Key Market Dynamics

5.1 Homeopathy Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Adoption of Homeopathic Medicine
- 5.2.2 Increasing Prevalence of Lifestyle-Related and Chronic Diseases
5.3 Market Restraints
- 5.3.1 Lack of Clinical Evidence for Homeopathy Medicines
5.4 Market Opportunities
- 5.4.1 Surging Healthcare Expenditure and Evolving Reimbursement Policies
5.5 Future Trends
- 5.5.1 Soaring Demand for Plant-Based Supplements and Launches of Innovative Homeopathic Remedies
5.6 Impact of Drivers and Restraints:

6. Homeopathy Market - Global Market Analysis

6.1 Homeopathy Market Revenue (US$ Million), 2021-2031
6.2 Homeopathy Market Forecast Analysis

7. Homeopathy Market Analysis - by Source

7.1 Plants
- 7.1.1 Overview
- 7.1.2 Plants: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Minerals
- 7.2.1 Overview
- 7.2.2 Minerals: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Animals
- 7.3.1 Overview
- 7.3.2 Animals: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)

8. Homeopathy Market Analysis - by Type

8.1 Dilutions
- 8.1.1 Overview
- 8.1.2 Dilutions: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Tinctures
- 8.2.1 Overview
- 8.2.2 Tinctures: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Biochemics
- 8.3.1 Overview
- 8.3.2 Biochemics: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Tablets
- 8.4.1 Overview
- 8.4.2 Tablets: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Ointments
- 8.5.1 Overview
- 8.5.2 Ointments: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)

9. Homeopathy Market Analysis - by Application

9.1 Neurology
- 9.1.1 Overview
- 9.1.2 Neurology: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Gastroenterology
- 9.2.1 Overview
- 9.2.2 Gastroenterology: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Respiratory
- 9.3.1 Overview
- 9.3.2 Respiratory: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Dermatology
- 9.4.1 Overview
- 9.4.2 Dermatology: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Immunology
- 9.5.1 Overview
- 9.5.2 Immunology: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)

10. Homeopathy Market Analysis - by End User

10.1 Homeopathic Clinics
- 10.1.1 Overview
- 10.1.2 Homeopathic Clinics: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Retail Pharmacies
- 10.2.1 Overview
- 10.2.2 Retail Pharmacies: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
10.3 e-Retailers
- 10.3.1 Overview
- 10.3.2 e-Retailers: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Others
- 10.4.1 Overview
- 10.4.2 Others: Homeopathy Market - Revenue and Forecast to 2031 (US$ Million)

11. Homeopathy Market - Geographical Analysis

11.1 Overview
11.2 North America
- 11.2.1 North America Homeopathy Market Overview
- 11.2.2 North America: Homeopathy Market - Revenue, 2021-2031 (US$ Million)
- 11.2.3 North America: Homeopathy Market Breakdown, by Source
  - 11.2.3.1 North America: Homeopathy Market - Revenue and Forecast Analysis - by Source
- 11.2.4 North America: Homeopathy Market Breakdown, by Type
  - 11.2.4.1 North America: Homeopathy Market - Revenue and Forecast Analysis - by Type
- 11.2.5 North America: Homeopathy Market Breakdown, by Application
  - 11.2.5.1 North America: Homeopathy Market - Revenue and Forecast Analysis - by Application
- 11.2.6 North America: Homeopathy Market Breakdown, by End User
  - 11.2.6.1 North America: Homeopathy Market - Revenue and Forecast Analysis - by End User
- 11.2.7 North America: Homeopathy Market - Revenue and Forecast Analysis - by Country
  - 11.2.7.1 North America: Homeopathy Market - Revenue and Forecast Analysis - by Country
  - 11.2.7.2 United States: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.7.2.1 United States: Homeopathy Market Breakdown, by Source
    - 11.2.7.2.2 United States: Homeopathy Market Breakdown, by Type
    - 11.2.7.2.3 United States: Homeopathy Market Breakdown, by Application
    - 11.2.7.2.4 United States: Homeopathy Market Breakdown, by End User
  - 11.2.7.3 Canada: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.7.3.1 Canada: Homeopathy Market Breakdown, by Source
    - 11.2.7.3.2 Canada: Homeopathy Market Breakdown, by Type
    - 11.2.7.3.3 Canada: Homeopathy Market Breakdown, by Application
    - 11.2.7.3.4 Canada: Homeopathy Market Breakdown, by End User
  - 11.2.7.4 Mexico: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.7.4.1 Mexico: Homeopathy Market Breakdown, by Source
    - 11.2.7.4.2 Mexico: Homeopathy Market Breakdown, by Type
    - 11.2.7.4.3 Mexico: Homeopathy Market Breakdown, by Application
    - 11.2.7.4.4 Mexico: Homeopathy Market Breakdown, by End User
11.3 Europe
- 11.3.1 Europe Homeopathy Market Overview
- 11.3.2 Europe: Homeopathy Market - Revenue, 2021-2031 (US$ Million)
- 11.3.3 Europe: Homeopathy Market Breakdown, by Source
  - 11.3.3.1 Europe: Homeopathy Market - Revenue and Forecast Analysis - by Source
- 11.3.4 Europe: Homeopathy Market Breakdown, by Type
  - 11.3.4.1 Europe: Homeopathy Market - Revenue and Forecast Analysis - by Type
- 11.3.5 Europe: Homeopathy Market Breakdown, by Application
  - 11.3.5.1 Europe: Homeopathy Market - Revenue and Forecast Analysis - by Application
- 11.3.6 Europe: Homeopathy Market Breakdown, by End User
  - 11.3.6.1 Europe: Homeopathy Market - Revenue and Forecast Analysis - by End User
- 11.3.7 Europe: Homeopathy Market - Revenue and Forecast Analysis - by Country
  - 11.3.7.1 Europe: Homeopathy Market - Revenue and Forecast Analysis - by Country
  - 11.3.7.2 United Kingdom: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.2.1 United Kingdom: Homeopathy Market Breakdown, by Source
    - 11.3.7.2.2 United Kingdom: Homeopathy Market Breakdown, by Type
    - 11.3.7.2.3 United Kingdom: Homeopathy Market Breakdown, by Application
    - 11.3.7.2.4 United Kingdom: Homeopathy Market Breakdown, by End User
  - 11.3.7.3 Germany: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.3.1 Germany: Homeopathy Market Breakdown, by Source
    - 11.3.7.3.2 Germany: Homeopathy Market Breakdown, by Type
    - 11.3.7.3.3 Germany: Homeopathy Market Breakdown, by Application
    - 11.3.7.3.4 Germany: Homeopathy Market Breakdown, by End User
  - 11.3.7.4 France: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.4.1 France: Homeopathy Market Breakdown, by Source
    - 11.3.7.4.2 France: Homeopathy Market Breakdown, by Type
    - 11.3.7.4.3 France: Homeopathy Market Breakdown, by Application
    - 11.3.7.4.4 France: Homeopathy Market Breakdown, by End User
  - 11.3.7.5 Italy: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.5.1 Italy: Homeopathy Market Breakdown, by Source
    - 11.3.7.5.2 Italy: Homeopathy Market Breakdown, by Type
    - 11.3.7.5.3 Italy: Homeopathy Market Breakdown, by Application
    - 11.3.7.5.4 Italy: Homeopathy Market Breakdown, by End User
  - 11.3.7.6 Spain: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.6.1 Spain: Homeopathy Market Breakdown, by Source
    - 11.3.7.6.2 Spain: Homeopathy Market Breakdown, by Type
    - 11.3.7.6.3 Spain: Homeopathy Market Breakdown, by Application
    - 11.3.7.6.4 Spain: Homeopathy Market Breakdown, by End User
  - 11.3.7.7 Rest of Europe: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.7.7.1 Rest of Europe: Homeopathy Market Breakdown, by Source
    - 11.3.7.7.2 Rest of Europe: Homeopathy Market Breakdown, by Type
    - 11.3.7.7.3 Rest of Europe: Homeopathy Market Breakdown, by Application
    - 11.3.7.7.4 Rest of Europe: Homeopathy Market Breakdown, by End User
11.4 Asia Pacific
- 11.4.1 Asia Pacific Homeopathy Market Overview
- 11.4.2 Asia Pacific: Homeopathy Market - Revenue, 2021-2031 (US$ Million)
- 11.4.3 Asia Pacific: Homeopathy Market Breakdown, by Source
  - 11.4.3.1 Asia Pacific: Homeopathy Market - Revenue and Forecast Analysis - by Source
- 11.4.4 Asia Pacific: Homeopathy Market Breakdown, by Type
  - 11.4.4.1 Asia Pacific: Homeopathy Market - Revenue and Forecast Analysis - by Type
- 11.4.5 Asia Pacific: Homeopathy Market Breakdown, by Application
  - 11.4.5.1 Asia Pacific: Homeopathy Market - Revenue and Forecast Analysis - by Application
- 11.4.6 Asia Pacific: Homeopathy Market Breakdown, by End User
  - 11.4.6.1 Asia Pacific: Homeopathy Market - Revenue and Forecast Analysis - by End User
- 11.4.7 Asia Pacific: Homeopathy Market - Revenue and Forecast Analysis - by Country
  - 11.4.7.1 Asia Pacific: Homeopathy Market - Revenue and Forecast Analysis - by Country
  - 11.4.7.2 India: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.2.1 India: Homeopathy Market Breakdown, by Source
    - 11.4.7.2.2 India: Homeopathy Market Breakdown, by Type
    - 11.4.7.2.3 India: Homeopathy Market Breakdown, by Application
    - 11.4.7.2.4 India: Homeopathy Market Breakdown, by End User
  - 11.4.7.3 China: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.3.1 China: Homeopathy Market Breakdown, by Source
    - 11.4.7.3.2 China: Homeopathy Market Breakdown, by Type
    - 11.4.7.3.3 China: Homeopathy Market Breakdown, by Application
    - 11.4.7.3.4 China: Homeopathy Market Breakdown, by End User
  - 11.4.7.4 Japan: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.4.1 Japan: Homeopathy Market Breakdown, by Source
    - 11.4.7.4.2 Japan: Homeopathy Market Breakdown, by Type
    - 11.4.7.4.3 Japan: Homeopathy Market Breakdown, by Application
    - 11.4.7.4.4 Japan: Homeopathy Market Breakdown, by End User
  - 11.4.7.5 Australia: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.5.1 Australia: Homeopathy Market Breakdown, by Source
    - 11.4.7.5.2 Australia: Homeopathy Market Breakdown, by Type
    - 11.4.7.5.3 Australia: Homeopathy Market Breakdown, by Application
    - 11.4.7.5.4 Australia: Homeopathy Market Breakdown, by End User
  - 11.4.7.6 South Korea: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.6.1 South Korea: Homeopathy Market Breakdown, by Source
    - 11.4.7.6.2 South Korea: Homeopathy Market Breakdown, by Type
    - 11.4.7.6.3 South Korea: Homeopathy Market Breakdown, by Application
    - 11.4.7.6.4 South Korea: Homeopathy Market Breakdown, by End User
  - 11.4.7.7 Rest of APAC: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.7.7.1 Rest of APAC: Homeopathy Market Breakdown, by Source
    - 11.4.7.7.2 Rest of APAC: Homeopathy Market Breakdown, by Type
    - 11.4.7.7.3 Rest of APAC: Homeopathy Market Breakdown, by Application
    - 11.4.7.7.4 Rest of APAC: Homeopathy Market Breakdown, by End User
11.5 Middle East and Africa
- 11.5.1 Middle East and Africa Homeopathy Market Overview
- 11.5.2 Middle East and Africa: Homeopathy Market - Revenue, 2021-2031 (US$ Million)
- 11.5.3 Middle East and Africa: Homeopathy Market Breakdown, by Source
  - 11.5.3.1 Middle East and Africa: Homeopathy Market - Revenue and Forecast Analysis - by Source
- 11.5.4 Middle East and Africa: Homeopathy Market Breakdown, by Type
  - 11.5.4.1 Middle East and Africa: Homeopathy Market - Revenue and Forecast Analysis - by Type
- 11.5.5 Middle East and Africa: Homeopathy Market Breakdown, by Application
  - 11.5.5.1 Middle East and Africa: Homeopathy Market - Revenue and Forecast Analysis - by Application
- 11.5.6 Middle East and Africa: Homeopathy Market Breakdown, by End User
  - 11.5.6.1 Middle East and Africa: Homeopathy Market - Revenue and Forecast Analysis - by End User
- 11.5.7 Middle East and Africa: Homeopathy Market - Revenue and Forecast Analysis - by Country
  - 11.5.7.1 Middle East and Africa: Homeopathy Market - Revenue and Forecast Analysis - by Country
  - 11.5.7.2 United Arab Emirates: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.2.1 United Arab Emirates: Homeopathy Market Breakdown, by Source
    - 11.5.7.2.2 United Arab Emirates: Homeopathy Market Breakdown, by Type
    - 11.5.7.2.3 United Arab Emirates: Homeopathy Market Breakdown, by Application
    - 11.5.7.2.4 United Arab Emirates: Homeopathy Market Breakdown, by End User
  - 11.5.7.3 Saudi Arabia: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.3.1 Saudi Arabia: Homeopathy Market Breakdown, by Source
    - 11.5.7.3.2 Saudi Arabia: Homeopathy Market Breakdown, by Type
    - 11.5.7.3.3 Saudi Arabia: Homeopathy Market Breakdown, by Application
    - 11.5.7.3.4 Saudi Arabia: Homeopathy Market Breakdown, by End User
  - 11.5.7.4 South Africa: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.4.1 South Africa: Homeopathy Market Breakdown, by Source
    - 11.5.7.4.2 South Africa: Homeopathy Market Breakdown, by Type
    - 11.5.7.4.3 South Africa: Homeopathy Market Breakdown, by Application
    - 11.5.7.4.4 South Africa: Homeopathy Market Breakdown, by End User
  - 11.5.7.5 Rest of Middle East and Africa: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.7.5.1 Rest of Middle East and Africa: Homeopathy Market Breakdown, by Source
    - 11.5.7.5.2 Rest of Middle East and Africa: Homeopathy Market Breakdown, by Type
    - 11.5.7.5.3 Rest of Middle East and Africa: Homeopathy Market Breakdown, by Application
    - 11.5.7.5.4 Rest of Middle East and Africa: Homeopathy Market Breakdown, by End User
11.6 South and Central America
- 11.6.1 South and Central America Homeopathy Market Overview
- 11.6.2 South and Central America: Homeopathy Market - Revenue, 2021-2031 (US$ Million)
- 11.6.3 South and Central America: Homeopathy Market Breakdown, by Source
  - 11.6.3.1 South and Central America: Homeopathy Market - Revenue and Forecast Analysis - by Source
- 11.6.4 South and Central America: Homeopathy Market Breakdown, by Type
  - 11.6.4.1 South and Central America: Homeopathy Market - Revenue and Forecast Analysis - by Type
- 11.6.5 South and Central America: Homeopathy Market Breakdown, by Application
  - 11.6.5.1 South and Central America: Homeopathy Market - Revenue and Forecast Analysis - by Application
- 11.6.6 South and Central America: Homeopathy Market Breakdown, by End User
  - 11.6.6.1 South and Central America: Homeopathy Market - Revenue and Forecast Analysis - by End User
- 11.6.7 South and Central America: Homeopathy Market - Revenue and Forecast Analysis - by Country
  - 11.6.7.1 South and Central America: Homeopathy Market - Revenue and Forecast Analysis - by Country
  - 11.6.7.2 Brazil: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.6.7.2.1 Brazil: Homeopathy Market Breakdown, by Source
    - 11.6.7.2.2 Brazil: Homeopathy Market Breakdown, by Type
    - 11.6.7.2.3 Brazil: Homeopathy Market Breakdown, by Application
    - 11.6.7.2.4 Brazil: Homeopathy Market Breakdown, by End User
  - 11.6.7.3 Argentina: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.6.7.3.1 Argentina: Homeopathy Market Breakdown, by Source
    - 11.6.7.3.2 Argentina: Homeopathy Market Breakdown, by Type
    - 11.6.7.3.3 Argentina: Homeopathy Market Breakdown, by Application
    - 11.6.7.3.4 Argentina: Homeopathy Market Breakdown, by End User
  - 11.6.7.4 Rest of South and Central America: Homeopathy Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.6.7.4.1 Rest of South and Central America: Homeopathy Market Breakdown, by Source
    - 11.6.7.4.2 Rest of South and Central America: Homeopathy Market Breakdown, by Type
    - 11.6.7.4.3 Rest of South and Central America: Homeopathy Market Breakdown, by Application
    - 11.6.7.4.4 Rest of South and Central America: Homeopathy Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration

13. Industry Landscape

13.1 Overview
13.2 Product Launch, Product Approvals
13.3 Mergers and Acquisitions
13.4 Partnerships
13.5 Company News

14. Company Profiles

14.1 Fourrts
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Boiron
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Biologische Heilmittel Heel GmbH
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Dr Reckeweg & Co GmbH
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Homeocan Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Dr. Schwabe Holding SE & Co. KG
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Hahnemann Laboratories, Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Qvik - Homeopathy
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Hevert-Arzneimittel GmbH & Co. KG.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Natura
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Fusion Homoeopathics
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments

15. Appendix

15.1 Glossary of Terms
15.2 About The Insight Partners